LSD1 ‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1 ‐Induced p62 Transcription in HCC

Author:

Ma Luyuan12ORCID,Xu An3,Kang Lei4,Cong Rui2,Fan Zhongyi5,Zhu Xiang2,Huo Nan2,Liu Wenpeng1,Xue Chunyuan2,Ji Quanbo6,Li Wenchao7,Chu Zhong2,Kang Xiaofeng2,Wang Yadong1,Sun Zhijia2,Han Yuchen2,Liu Hanxiao2,Gao Xiang8,Han Juqiang7,You Hua9,Zhao Caiyan1,Xu Xiaojie2

Affiliation:

1. Department of Infectious Diseases the Third Hospital of Hebei Medical University Shijiazhuang China

2. Department of Genetic Engineering Beijing Institute of Biotechnology Beijing China

3. Department of Oncology Second Medical Center of Chinese PLA General Hospital Beijing China

4. Department of Nuclear Medicine Peking University First Hospital Beijing China

5. Department of Oncology and Hematology Shenzhen Third People’s HospitalSecond Hospital Affiliated to Southern University of Science and Technology Shenzhen China

6. Department of Orthopedics First Medical Center of Chinese PLA General Hospital Beijing China

7. Seventh Medical Center of Chinese PLA General Hospital Beijing China

8. State Key Laboratory of Toxicology and Medical Countermeasures Beijing Institute of Pharmacology and Toxicology Beijing China

9. Department of Oncology Affiliated Cancer Hospital & Institute of Guangzhou Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3